Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
상품코드:1642423
리서치사:Fairfield Market Research
발행일:2025년 01월
페이지 정보:영문 179 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 기침약 시장 규모는 꾸준히 증가하여 2025년에는 287억 5,000만 달러로 급증하고 2032년에는 443억 8,000만 달러로 더욱 성장할 것으로 예상됩니다. 이러한 성장에는 호흡기질환의 증가, 소비자 인식의 증가, 제약 솔루션의 발전이 기여하고 있으며, CAGR은 6.4%입니다.
기침약(진해제)은 기침의 충동을 최소화하기 위해 처방되는 의약품입니다. 이들 의약품은 뇌의 기침 반사에 영향을 미쳐 작용하며 호흡기 감염, 알레르겐, 환경오염물질로 인한 증상 완화에 도움을 줍니다. 이 시장에서는 환자의 편의성과 치료성 향상을 위해 새로운 약물의 조합, 전달 메커니즘 강화 등 기술 혁신의 물결이 일고 있습니다.
소비자들의 건강에 대한 인식이 높아지면서 일반의약품(OTC) 기침약에 대한 수요가 확대되고 있습니다. 공해, 계절성 감염, 알레르겐 등 다양한 호흡기질환의 확산이 시장 확대를 견인하고 있습니다. 소비자들은 지속적인 기침에 대한 효과적인 치료법을 적극적으로 찾고 있으며, 이는 기침약 제품 판매를 증가시키고 있습니다. 업체들은 효능을 개선하고 부작용을 줄인 제제 개발에 주력하고 있습니다. 시장은 여러 유효 성분을 통합하여 종합적인 완화를 도모하는 복합 요법으로 전환하고 있습니다. 액상 캡슐, 가글, 스프레이 등 보다 사용하기 쉬운 제형이 소비자들에게 인기를 끌고 있습니다.
세계의 기침약 시장에 대해 조사했으며, 시장 개요와 함께 종류별, 약품별, 형태별, 유통 채널별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
시장 정의와 세분화
시장 역학
밸류체인 분석
Porter's Five Forces 분석
COVID-19의 영향 분석
우크라이나·러시아 분쟁의 영향
경제 개요
PESTLE 분석
제3장 가격 분석, 2019-2023년
제4장 세계의 기침약 시장 전망, 2019-2032년
세계의 기침약 시장 전망, 유형별, 금액(10억 달러), 수량(개), 2019-2032년
세계의 기침약 시장 전망, 약제별, 금액(10억 달러), 수량(개), 2019-2032년
세계의 기침약 시장 전망, 형태별, 금액(10억 달러), 수량(개), 2019-2032년
세계의 기침약 시장 전망, 유통 채널별, 금액(10억 달러), 수량(개), 2019-2032년
세계의 기침약 시장 전망, 지역별, 금액(10억 달러), 수량(개), 2019-2032년
제5장 북미의 기침약 시장 전망, 2019-2032년
제6장 유럽의 기침약 시장 전망, 2019-2032년
제7장 아시아태평양의 기침약 시장 전망, 2019-2032년
제8장 라틴아메리카의 기침약 시장 전망, 2019-2032년
제9장 중동 및 아프리카의 기침약 시장 전망, 2019-2032년
제10장 경쟁 구도
유형별 vs약제별 히트맵
기업 시장 점유율 분석, 2024년
경쟁 대시보드
기업 개요
Abbott Laboratories
Acella Pharmaceuticals, LLC
GlaxoSmithKline Plc
Johnson & Johnson services Inc.
Merck KGaA
Novartis International AG
Pfizer Inc.
Procter & Gamble
제11장 부록
ksm
영문 목차
영문목차
The global market for cough suppressants is on a steady rise, with projections indicating a surge in value to USD 28.75 billion by 2025 and further growth to USD 44.38 billion by 2032. This expansion is fueled by increasing respiratory ailments, heightened consumer awareness, and advancements in pharmaceutical solutions, driving a compound annual growth rate (CAGR) of 6.4%.
Market Dynamics
Cough suppressants, or antitussives, are pharmaceutical products formulated to minimize the urge to cough. These medications work by influencing the brain's cough reflex, helping alleviate symptoms caused by respiratory infections, allergens, and environmental pollutants. The market is witnessing a wave of innovations, including novel drug combinations and enhanced delivery mechanisms, aimed at improving patient convenience and treatment outcomes.
Growth Drivers
Increasing Health Consciousness & Respiratory Conditions
A rise in consumer health awareness is leading to a greater demand for over-the-counter (OTC) cough treatments.
The growing prevalence of respiratory illnesses due to pollution, seasonal infections, and allergens is pushing market expansion.
Consumers are actively seeking effective remedies for persistent coughs, increasing sales of cough suppressant products.
Innovation & Expansion in Product Offerings
Companies are prioritizing R&D to develop enhanced formulations with improved efficacy and reduced side effects.
The market is shifting toward combination therapies that integrate multiple active ingredients for comprehensive relief.
More user-friendly formats, including liquid capsules, lozenges, and sprays, are gaining popularity among consumers.
Business Opportunities
Development of Pediatric-Specific Products
Expanding product lines to include child-friendly formulations with appealing flavors and easy-to-administer formats can address unmet demand.
Parents are increasingly searching for safe and effective cough treatments for children, presenting an untapped growth area.
Demand for Natural & Herbal Cough Remedies
The increasing preference for natural remedies is encouraging manufacturers to introduce cough suppressants with herbal ingredients such as honey, ginger, and botanical extracts.
Brands that cater to the trend of holistic wellness and natural healthcare will have a competitive advantage in the market.
Market Challenges
Regulatory Constraints
Stricter regulations on OTC medications pose challenges for market players in terms of compliance and approval.
Continuous investment in research and development is necessary to ensure products meet evolving quality and safety standards.
Supply Chain Issues
Rising consumer demand, particularly during peak seasons, puts pressure on supply chains.
Raw material shortages, logistical barriers, and workforce disruptions create hurdles in maintaining product availability.
Companies must adopt resilient supply chain strategies to maintain consistent distribution.
Regional Insights
Europe: Market Leader
The region benefits from strong healthcare systems, a high incidence of respiratory conditions, and an aging population with greater susceptibility to cough-related ailments.
Strict pharmaceutical regulations ensure high product quality, reinforcing consumer trust and market stability.
A growing preference for self-medication and increased awareness of OTC cough remedies contribute to market expansion.
South Asia & Pacific: Fastest-Growing Market
Rising awareness about health and increasing respiratory issues drive demand for cough suppressants in this region.
Changing environmental conditions and lifestyle factors contribute to a rise in respiratory infections, fueling market growth.
A developing healthcare Analysis and a shift toward OTC medication usage make this region an emerging hotspot for market expansion.
Leading Market Players
The cough suppressant market is highly competitive, with key players focusing on innovation and strategic growth. Notable companies in the sector include:
Abbott Laboratories
Acella Pharmaceuticals, LLC
GlaxoSmithKline Plc
Johnson & Johnson Services Inc.
Merck KGaA
Novartis International AG
Pfizer Inc.
Procter & Gamble
Noteworthy Developments
New Product Introductions
2021: Sun Pharmaceutical Industries introduced Chericof 12 in India, featuring an advanced formulation designed to enhance patient recovery from cough symptoms.
Market Impact: This innovation highlights the pharmaceutical sector's commitment to addressing evolving healthcare needs with effective cough suppressant solutions.
Strategic Acquisitions
2023: GSK Plc acquired Bellus Health Inc., strengthening its portfolio of treatments for cough and related respiratory conditions.
Market Impact: This acquisition reinforces GSK's position in the market, enhancing its ability to provide diverse and effective cough suppressant solutions while expanding its global reach.
Market Segmentation
The cough suppressant market is categorized based on type, active ingredients, form, sales channels, and geography.
By Type:
Acute Cough
Chronic Cough
By Active Ingredients:
Dextromethorphan
Codeine
Butramirate
Benzonatate
Others
By Form:
Tablets/Capsules
Liquid Syrups
Sprays
By Sales Channels:
Hospitals
Retail Pharmacies
Drug Stores
E-commerce Platforms
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Table of Contents
1. Executive Summary
1.1. Global Cough Suppressant Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2019 - 2023
3.1. Global Average Price Analysis by Type, 2019 - 2023
